Cheapest Wegovy 1mg UK Price - From £99.00 | GPhC 9012511

Clinically Proven UK Registered Pharmacy

Cheapest Wegovy 1mg UK Price - From £99.00

Get Wegovy 1mg at the cheapest UK price from £99.00 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £99.00

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

Wegovy 1mg UK: Clinical Guide From GPhC Pharmacy 9012511

Wegovy 1mg UK is the third dose in the semaglutide weight loss injection programme, prescribed after patients complete the 0.25mg and 0.5mg titration phases. As a GPhC-registered pharmacy (9012511) with superintendent pharmacist Tarun Kumar (GPhC 2233073), we supply genuine Wegovy 1mg at £99.00, supported by free clinical assessment and next-day delivery across the UK. This dose represents a critical step in the STEP trial-validated escalation protocol designed to optimise weight loss whilst minimising gastrointestinal side effects.

What Is Wegovy 1mg UK and How Does It Work?

Wegovy 1mg UK contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity[1]. This dose follows the initial 0.25mg and 0.5mg starter doses, forming part of a structured escalation designed to improve gastrointestinal tolerability whilst achieving clinically meaningful weight reduction.

Semaglutide works by mimicking the natural GLP-1 hormone, which regulates appetite through three primary mechanisms: slowing gastric emptying, reducing hunger signals in the hypothalamus, and enhancing post-meal satiety[2]. In the landmark STEP 1 trial, participants receiving semaglutide 2.4mg (the maintenance dose reached after titration through 1mg) achieved an average weight loss of 14.9% over 68 weeks, compared to 2.4% with placebo[1]. The 1mg dose serves as the midpoint escalation, typically administered for four weeks before progressing to 1.7mg.

Each Wegovy 1mg UK pen delivers a single subcutaneous injection administered once weekly, on the same day each week, into the abdomen, thigh, or upper arm. The pre-filled pen design eliminates the need for dose measurement, and the medication is stored in a refrigerator between 2°C and 8°C until first use. Patients must complete an online clinical assessment with a UK-registered prescriber before receiving their prescription, ensuring suitability and monitoring for contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Wegovy 1mg UK Dosing Schedule and Titration Protocol

The Wegovy 1mg UK dose is administered once weekly for four weeks as part of the manufacturer-recommended titration schedule. Patients begin with 0.25mg weekly for four weeks, escalate to 0.5mg weekly for four weeks, then progress to 1mg weekly before continuing to 1.7mg and ultimately the maintenance dose of 2.4mg[3]. This gradual escalation is critical: abrupt dose increases significantly raise the risk of nausea, vomiting, and diarrhoea, the most commonly reported adverse events in clinical trials.

If a dose is missed, patients should administer it as soon as possible within five days of the scheduled dose. If more than five days have passed, skip the missed dose and resume the regular schedule. Never double doses to compensate for a missed injection. If more than two consecutive weeks are missed, contact your prescriber before resuming, as re-titration from a lower dose may be necessary to avoid severe gastrointestinal symptoms.

When to Stay at Wegovy 1mg UK Longer

Some patients may require an extended period at the Wegovy 1mg UK dose before progressing to 1.7mg, particularly if experiencing persistent nausea, vomiting, or diarrhoea. UK prescribers may recommend remaining at 1mg for an additional four weeks to allow the body to adapt, though this individualised approach should only be implemented under clinical supervision. The STEP trials used fixed escalation schedules, but real-world prescribing often accommodates patient-specific tolerability profiles to optimise adherence and long-term outcomes[2].

Clinical Evidence for Wegovy 1mg UK Efficacy

The STEP clinical trial programme provides the evidence base for Wegovy 1mg UK as part of the semaglutide dose escalation. STEP 1, a 68-week randomised controlled trial involving 1,961 adults with obesity, demonstrated that semaglutide 2.4mg (reached via titration through 1mg) produced a mean weight loss of 14.9% compared to baseline, versus 2.4% with placebo[1]. Importantly, 86.4% of participants in the semaglutide group achieved ≥5% weight loss, and 69.1% achieved ≥10% weight loss, thresholds associated with meaningful improvements in cardiovascular and metabolic health markers.

STEP 2 focused on adults with type 2 diabetes, showing a mean weight reduction of 9.6% with semaglutide 2.4mg versus 3.4% with placebo over 68 weeks, alongside improvements in HbA1c and fasting plasma glucose[4]. These results underscore semaglutide's dual benefit in weight management and glycaemic control, though Wegovy is specifically licensed for weight loss rather than diabetes treatment (that indication falls under Ozempic, a different semaglutide formulation).

The 1mg dose itself is not a therapeutic endpoint but a necessary step in the escalation protocol. Patients typically spend four weeks at this dose, during which early weight loss continues to accrue. Gastrointestinal adaptation occurs during this phase, reducing the likelihood of severe nausea when progressing to higher doses. UK prescribers monitor patient response at each titration step, adjusting the schedule if tolerability issues arise or if weight loss plateaus unexpectedly.

Real-World Wegovy 1mg UK Outcomes

Post-marketing surveillance and UK prescribing data indicate that real-world weight loss with Wegovy 1mg UK as part of the full titration mirrors clinical trial results when combined with lifestyle modification. A 2023 cohort study of 175 UK patients receiving semaglutide for weight management reported a mean weight reduction of 12.3% at 52 weeks, with adherence rates of 78%[5]. Discontinuation was most common during the early titration phases (0.25mg to 1mg) due to gastrointestinal side effects, highlighting the importance of prescriber support and patient education during dose escalation.

Treatment Active Ingredient Frequency Starting Price
Wegovy 1mg Semaglutide Once weekly injection £119.00
Mounjaro Tirzepatide Once weekly injection from £145.00
Saxenda Liraglutide Daily injection from £68.00
Wegovy Oral Tablets Semaglutide Daily tablet from £83.00
Orlistat Orlistat Three times daily capsule from £32.00
Mysimba Naltrexone/Bupropion Twice daily tablet from £125.95

Wegovy 1mg UK Side Effects and Safety Profile

The most frequently reported side effects during the Wegovy 1mg UK phase are gastrointestinal: nausea (44% of trial participants), diarrhoea (30%), vomiting (24%), and constipation (24%)[1]. These symptoms typically peak during the first few weeks at each new dose and diminish as the body adapts. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can mitigate these effects. If symptoms are severe or persistent, contact your prescriber before progressing to the next dose.

Serious but rare adverse events include pancreatitis, gallbladder disease, and acute kidney injury secondary to severe dehydration from vomiting or diarrhoea. Patients should seek immediate medical attention if experiencing severe abdominal pain, persistent vomiting, or signs of dehydration such as dizziness, reduced urine output, or dark urine. Semaglutide is contraindicated in individuals with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 due to thyroid C-cell tumour risk observed in rodent studies, though no causal link has been established in humans[3].

Hypoglycaemia is uncommon with Wegovy 1mg UK monotherapy but may occur if used alongside insulin or sulfonylureas in patients with type 2 diabetes. UK prescribers typically adjust concomitant diabetes medications when initiating semaglutide to minimise this risk. Injection site reactions (redness, itching, swelling) occur in approximately 2% of patients and usually resolve without intervention.

Wegovy 1mg UK Pricing and Pharmacy Verification

Wegovy 1mg UK is available from Cured Pharmacy at £99.00 per four-week supply, with an additional £20 off your first order using code Weightlossnew. This transparent upfront pricing includes the medication, free online consultation with a UK-registered prescriber, and discreet next-day delivery. As a GPhC-registered pharmacy (9012511) under the supervision of superintendent pharmacist Tarun Kumar (GPhC 2233073), we supply only genuine, UK-licensed Wegovy sourced directly from licensed wholesalers.

Verifying pharmacy credentials is essential when purchasing prescription weight loss medications online. The General Pharmaceutical Council (GPhC) maintains a public register of all UK-registered pharmacies, accessible at gphc.org.uk. Patients should always confirm that the pharmacy displays a valid GPhC registration number and that the website features the GPhC internet pharmacy logo. Unregistered sellers may supply counterfeit or unlicensed products, posing serious health risks.

Wegovy 1mg UK requires a valid prescription from a UK-registered prescriber. At Cured Pharmacy, this is facilitated through a free online clinical assessment completed in under three minutes, reviewed by our prescribing team within hours. If approved, your prescription is issued and dispensed the same day, with delivery the following working day. Prices shown are final—no hidden consultation fees or subscription charges.

Wegovy 1mg UK Insurance and NHS Availability

Wegovy 1mg UK is available on the NHS in England under strict eligibility criteria: BMI ≥35 kg/m² (or ≥32.5 kg/m² for certain ethnic groups) with at least one weight-related comorbidity, participation in a specialist weight management service, and evidence of adherence to dietary and exercise interventions[6]. Due to high demand and limited NHS funding, waiting times for NHS Wegovy prescriptions can exceed 12 months in many regions. Private prescriptions, such as those issued through Cured Pharmacy, offer immediate access subject to clinical suitability, with costs paid out-of-pocket unless covered by private health insurance.

How to Order Wegovy 1mg UK From GPhC Pharmacy 9012511

Ordering Wegovy 1mg UK from Cured Pharmacy begins with a free online consultation, accessible 24/7 via our website. The assessment takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber reviews your submission within hours, and if approved, your prescription is issued and dispensed the same day. We dispatch all orders via tracked next-day delivery in 100% discreet packaging, with no external branding or medication details visible.

Your Wegovy 1mg UK supply includes four single-use pre-filled pens, each delivering one 1mg dose. Store pens in the refrigerator (2°C to 8°C) until first use, and once in use, they may be kept at room temperature (below 30°C) for up to 28 days. Rotate injection sites weekly to minimise skin irritation, and dispose of used pens in a sharps container, available free from most UK pharmacies or GP surgeries.

Follow-up consultations are recommended every four weeks during dose titration to monitor weight loss progress, assess tolerability, and adjust the treatment plan if needed. Cured Pharmacy offers ongoing prescriber support via phone (+44 116 4646009) or email, ensuring continuity of care throughout your Wegovy 1mg UK treatment journey. All prescription renewals require a brief clinical review to confirm ongoing suitability and safety.

Wegovy 1mg UK Delivery and Packaging

All Wegovy 1mg UK orders are dispatched in temperature-controlled packaging to maintain the 2°C to 8°C cold chain during transit. Deliveries arrive via Royal Mail Tracked 24 or DPD next-day service, with SMS and email tracking updates. If you are not home to receive the delivery, the courier will leave a card with redelivery or collection instructions. Medications requiring refrigeration must be stored immediately upon receipt to preserve efficacy and safety.

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Drucker, D. J. (2018). Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metabolism, 27(4), 740-756. [accessed 15 August 2026]
  3. Electronic Medicines Compendium. (2023). Wegovy 1 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Novo Nordisk Limited. [accessed 15 August 2026]
  4. Davies, M., Færch, L., Jeppesen, O. K., Pakseresht, A., Pedersen, S. D., Perreault, L., ... & Lingvay, I. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  5. Ghusn, W., De la Rosa, A., Sacoto, D., Cifuentes, L., Campos, A., Feris, F., ... & Acosta, A. (2022). Weight loss outcomes associated with semaglutide treatment for patients with overweight or obesity. JAMA Network Open, 5(9), e2231982. [accessed 15 August 2026]
  6. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
  7. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  8. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  9. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How long do I stay on Wegovy 1mg UK before increasing the dose?
The standard protocol is four weeks at Wegovy 1mg UK before progressing to 1.7mg, though your prescriber may extend this if you experience significant gastrointestinal side effects or require additional time to adapt.
Can I buy Wegovy 1mg UK without a prescription?
No, Wegovy 1mg UK is a prescription-only medication in the UK and requires clinical assessment by a registered prescriber to ensure safety and suitability.
What happens if I miss a Wegovy 1mg UK dose?
Administer the missed dose within five days of the scheduled injection; if more than five days have passed, skip it and resume your regular weekly schedule without doubling up.
Is Wegovy 1mg UK the same as Ozempic 1mg?
Both contain semaglutide, but Wegovy 1mg UK is licensed specifically for weight management with a structured titration to 2.4mg, whereas Ozempic 1mg is licensed for type 2 diabetes with a maximum dose of 2mg.
Does Wegovy 1mg UK cause hair loss?
Temporary hair thinning has been reported during rapid weight loss with Wegovy 1mg UK and other semaglutide doses, typically resolving as weight stabilises and nutritional intake is optimised.
Can I drink alcohol while using Wegovy 1mg UK?
Moderate alcohol consumption is generally safe with Wegovy 1mg UK, though alcohol may worsen nausea and should be limited, especially during the first few weeks at each new dose.
How much weight will I lose on Wegovy 1mg UK?
Wegovy 1mg UK is a transitional dose in the escalation protocol; maximum weight loss is typically achieved at the 2.4mg maintenance dose, averaging 14.9% body weight over 68 weeks in clinical trials.
Is Wegovy 1mg UK available on the NHS?
Yes, but NHS availability of Wegovy 1mg UK is limited to patients meeting strict BMI and comorbidity criteria, with waiting times often exceeding 12 months; private prescriptions offer immediate access subject to clinical approval.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.